UNSPSC 51282110: Floxacillin or flucloxacillin

This classification denotes a penicillin antibiotic with the molecular formula C19H17ClFN3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 43B2M34G2V, chemically known as 6-(3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as floxacillin, which bears US NIH Compound Identifier 21319. European Medicines Agency schedules Floxacillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07673MIG.

UNSPSC 51282110 Floxacillin or flucloxacillin is a Commodity code that nominally covers a specific antibiotic pharmaceutical product, but recent state and local opportunities show minimal activity tagged directly to this code. The two most recent records in the opportunity block do not represent solicitations for floxacillin or flucloxacillin itself. The Illinois Department of Public Health awarded a completed pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—different antibiotics entirely. Seminole County, Florida posted an IFB on June 30, 2026 for Naloxone and Safe Drug Deactivation Systems, which falls outside antibiotic procurement. These records suggest the code sees limited direct procurement activity or that state and local buyers are tagging pharmaceutical acquisitions to codes that do not match the actual products being purchased.

The available data does not support characterization of issuing-body mix, geographic concentration, or recent representative opportunities for floxacillin or flucloxacillin procurement specifically. The pharmaceutical warehouse activity noted in Illinois and the emergency-response drug procurement in Florida do not establish a pattern of demand for this specific antibiotic. Firms pursuing opportunities under this code should verify whether state and local buyers are actively soliciting floxacillin or flucloxacillin through dedicated RFPs, RFQs, or cooperative purchasing vehicles, as the current record does not demonstrate active or recent market engagement at the Commodity level.